Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+](c)/ROS-pathway in human endothelial cells

Authors :: Uthman, L.
Li, Xiaoling
Baartscheer, Antonius
Schumacher, Cees A.
Baumgart, Patricia
Hermanides, Jeroen
Zuurbier, C.J.
Weber, N.C.
Uthman, L.
Li, Xiaoling
Baartscheer, Antonius
Schumacher, Cees A.
Baumgart, Patricia
Hermanides, Jeroen
Zuurbier, C.J.
Weber, N.C.
Source :: Biomedicine & Pharmacotherapy; 0753-3322; 146; 112515; ~Biomedicine & Pharmacotherapy~~~~~0753-3322~~146~~112515
Publication Year :: 2022
Abstract: Contains fulltext : 242512.pdf (Publisher’s version ) (Open Access)

Database :: OAIster
Journal :: Biomedicine & Pharmacotherapy; 0753-3322; 146; 112515; ~Biomedicine & Pharmacotherapy~~~~~0753-3322~~146~~112515
Publication Type :: Electronic Resource
Accession number :: edsoai.on1367150274
Document Type :: Electronic Resource

Tools